MOST RECENT

New HPOS Education Resource

The Health Professional Education Resources Gateway offers a vast and growing range of customised educational resources for health professionals. We are excited to announce the addition of a new education resource that examines Health Professional Online Services (HPOS). This new simulation, HPOS Fundamentals, gives providers and their delegates,

  • An insight on setting up HPOS,
  • Overview of the key HPOS features, and
  • Closer analysis of some specific HPOS features.

To view and learn more about our new simulation, copy the following website URL into your browser address bar.

medicareaust.com/MODULES/HPOS/HPOSM02_1/index.html

More information

HPOS is an internet based portal, providing a simple and secure way for health professionals and organisations to do business with government online. HPOS enables online self-service access to government programs, payments and services. You need a Provider Digital Access (PRODA) account to access HPOS.

The Health Professional Education Resources Gateway contains an extensive range of tailored education resources to assist with setting up PRODA and HPOS. It also provides guidance on how to perform functions available in PRODA and HPOS.  You can acquire our full range of health professional education resources on our website by simply:

  • typing Medicareaust.com/index in your browser address bar
  • select play to continue
  • then select Health Professional Education Resources Gateway hyperlink to view the catalogue of resources.

Contact us:

Your opinion matters to us! 

If you have identified a need for a new educational product or have any feedback that could help us improve our existing resources, please let us know.

Did you know? We are currently revamping our website, which will be launched later this year. If you have any ideas or suggestions that you want to share with us please contact us via email at Medicare.Education@servicesaustralia.gov.au we would love to hear from you!

 

Download the document - New HPOS Education Resource

Timely and accurate reporting of vaccinations to the Australian Immunisation Register (AIR)

Reporting timely, high quality and accurate vaccination information ensures that the AIR contains a complete and reliable dataset to enable the monitoring of immunisation coverage and administration. It also ensures that individuals have a complete record of their vaccinations that can be provided as evidence for education, employment, and/or travel purposes.

Under the Australian Immunisation Register Act 2015 it is mandatory for vaccination providers to report all COVID-19, influenza, and National Immunisation Program vaccinations to the AIR.

To ensure accurate and complete reporting of vaccination information to the AIR, vaccination providers must provide the following information:

  • provider information: provider number, name and contact details
  • personal information of the individual vaccinated: Medicare number (if applicable), name, contact details, date of birth and gender
  • vaccine information: brand name, dose number and batch number and date of administration.

Batch Numbers

It has been identified that a significant number of AIR records have a batch number that has been recorded incorrectly. 

Please make sure that you are reporting the correct batch number to the AIR. The Department is aware that some Practice Management Software stores and/or autofill's previously entered information which can lead to data entry errors, it is important to correct this information prior to submission.

Reporting medical contraindications to the AIR

When reporting a medical contraindication to the AIR is important for eligible health professionals to complete the Australian Immunisation Register Immunisation Medical Exemption (IM011) form in line with the latest clinical guidance in the Australian Immunisation Handbook, for NIP vaccines, or from the Australian Technical Advisory Group on Immunisation for COVID.

Vaccination providers are reminded not to include any additional information such as clinical notes or test results and/or attach letters when recording a medical contraindication. This may cause delays in processing and if the IM011 form is incomplete, invalid, or unsigned it will be returned to the vaccination provider.

The quickest and easiest way to record all vaccination information is via the AIR site in HPOS or the relevant Practice Management Software.

For further information on reporting information to the AIR please visit: servicesaustralia.gov.au/hpair.

From: Nicholas Stoney

Assistant Secretary, Immunisation and Communicable Diseases Branch, Australian Government Department of Health

From this week, packs of the prescription-only medication, Tamiflu (oseltamivir), an oral antiviral used to treat and prevent influenza A and B infections, will be deployed to residential aged care facilities (RACFs) in a one-off pre-placement. This is part of the Department of Health’s 2022 winter preparedness plan.

This stock is being pre-placed to ensure access to supplies at the commencement of this year’s flu season. This is not intended to replace standard supply chains used by providers, rather it reduces the impacts of supply shortages within the private market and the delays in shipping that may result from increased demand during the winter period.

RACFs will need to source additional supply through community pharmacies in line with normal arrangements once the pre-placed stock has been expended.

RACFs in Western Australia without permits to hold medications will need to access the pre-placed stock through WA Health. In the event of an influenza outbreak, they should contact their Public Health Unit to request urgent approval to have a deployment of Commonwealth Government stocks. 

Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. Nurse practitioners should check whether they have authority to prescribe Tamiflu under their relevant state or territory medicines and poison legislation.

Leanne, I would appreciate your advice on how we can share this information more widely to Nurse Practitioners who may not be members of the college, please don’t hesitate to get in touch.

Thank you for helping to support older members of our community through this year’s flu season.

Kind regards

Professor (Practice) Alison J McMillan PSM

Chief Nursing and Midwifery Officer

Today, the Foundation for Alcohol Research and Education (FARE) has released a new report - Alcohol use and harms during the COVID-19 pandemic - which monitored emerging evidence in Australia during the COVID-19 pandemic (2020-21).

Alcohol-use-and-harms-during-the-COVID-19-pandemic

270522 - COVID-19 sees surge in Aussies seeking alcohol support services

This is a follow up to our 2020 evidence summary. We hope it provides a useful resource for our sector.

The report found:

  • High levels of stress and anxiety, as well as boredom and isolation, have been identified as key drivers of risky alcohol use during the pandemic.
  • Studies have also found childcare pressures and employment instability were drivers of increased alcohol use.
  • Increases in alcohol-related deaths and soaring demand for support services. There has been a tripling of calls to the National Alcohol and Other Drug Hotline since the pandemic began.

 

Please find attached, FARE’s Alcohol use and harms during the COVID-19 pandemic

The Australian Contraception and Abortion Primary Care Practitioner Support Network (AusCAPPS) enables GPs, nurse practitioners, nurses and pharmacists to connect and chat with like-minded peers and expert clinicians about long-acting reversible contraception and medical abortion, find local providers, and, get informed with the latest training opportunities, research, and resources. 

Website link: https://medcast.com.au/communities/auscapps?utm_source=Advertising&utm_medium=Website&utm_campaign=ACNP_website_May22

AusCAPPS banner

A change is being implemented on 1st April will see a few additional questions added to the provider number application form, in order to remove one step in the process of approval.  Please read the Communique here

Top 10 unanswered questions about medicines in people living with dementia

As determined by people living with dementia, and their carers, family and friends, and healthcare professionals.


This project aimed to identify the Top 10 unanswered questions related to quality use of medicines for people living with dementia.
The views of people who live with medical conditions and those who treat and care for them provide important insights into what research is most needed. Getting their perspectives helps to make sure that the right research is being done and makes the best use of valuable research funding.
‘Quality Use of Medicines’: using medicines safely and effectively, and selecting the best treatment for the individual (including not using medicines) to obtain optimal health outcomes. It also means only using medicines when they are needed.
 

Our work
We worked together with people living with dementia, carers and healthcare professionals to find the Top 10 research priorities for quality use of medicines in people living with dementia. We used a multi-step research process. First, we assembled a Stakeholder Steering Group and recruited Partner Organisations to ensure that the process stayed focused on the views and perspectives of stakeholders, and also to help disseminate our findings. Second, a national survey asked consumers and healthcare professionals what questions they have had about medicine use in people living with dementia. These questions were then assessed to determine if there is already an ‘answer’ – that is, had high quality research already been done? Third, we conducted a second national survey where we asked consumers and healthcare professionals to pick the unanswered questions that are the most important to them. This information then informed a workshop where consumers and healthcare professionals worked together to determine the Top 10 priorities for research in quality use of medicines in people living with dementia.  Throughout this process we engaged with and heard from over 300 consumers and 150 healthcare professionals from across Australia!
 

What’s next?
Our overall goal is to have research fundings and research efforts in Australia directed towards these Top 10 questions. This will ensure that outcomes of research are directly relevant to the care of people living with dementia.  We cannot do this alone! Contact us to find out how you can help!

Consumer and healthcare professional Top 10 unanswered questions about quality use of medicines in people living with dementia: priorities for research

  1. How can shared decision making about medicines be achieved between healthcare professionals and people living with dementia and their carers?
  2. What are effective ways to ensure that healthcare professionals have the necessary knowledge and skills to achieve safe effective and appropriate medication use in people living with dementia?
  3. How can communication between healthcare professionals be optimised, especially at transitions of care, to achieve multi-disciplinary care for people living with dementia?
  4. Which medicines are potentially harmful or unnecessary in people living with dementia and should be stopped? And how can deprescribing (cessation of harmful and/or unnecessary medicines) be achieved in people living with dementia?
  5. When, how and in who should medicines be used to manage pain in people living with dementia?
  6. How can people living with dementia and their carers be supported to manage medicines safely at home?
  7. When and how should medicines be used to treat changed behaviours (previously referred to as behavioural and psychological symptoms of dementia)? Including for different types of dementia. And how to safely and effectively reduce the use of antipsychotics (for changed behaviours) in people living with dementia?
  8. How can residential aged care facilities best achieve safe, effective and appropriate medicine use in residents with dementia?
  9. When, how and in who should medicines be used to treat depression and anxiety in people living with dementia?
  10. What is the optimal model for medicine reviews to achieve safe, effective and appropriate medicine use in people living with dementia? Including who should be involved, how often should reviews be conducted, and what follow-up is needed?

This work was proudly supported by the AAG Research Trust and the Dementia Australia Research Foundation - 2019 Strategic Research Grant. It would not have been possible without our Research Team, Stakeholder Steering Group, Partner Organisations and JLA advisor.
 

Research Team

  • Emily Reeve (Lead Investigator), University of South Australia
  • Nagham Ailabouni, University of South Australia
  • Lynn Chenoweth, University of New South Wales
  • Julia Gilmartin-Thomas, Victoria University
  • Sarah N Hilmer, University of Sydney and Royal North Shore Hospital
  • Lisa Kalisch Ellett, University of South Australia
  • Tuan Anh Nguyen, National Ageing Research Institute
  • Lyntara S Quirke, consumer representative
  • Mouna Sawan, Monash University
  • Janet K Sluggett, University of South Australia
  • Edwin Tan, University of Sydney
  • JLA advisor: Katherine Cowan
  • Stakeholder Steering Group
  • Stephanie Daly
  • Judy Deimel
  • Lenore de la Perrelle
  • Timothy Pietsch
  • Ann Pietsch
  • Ron Sinclair
  • Josephine To
  • Craig Whitehead
  • Marie Wittwer
  • Partner Organisations
  • Australian Association of Consultant Pharmacy,
  • Australian Association of Gerontology
  • Australian College of Nurse Practitioners,
  • Australian Nursing and Midwifery Federation,
  • Consumers Health Forum of Australia,
  • Leading Age Services Australia,
  • National Aboriginal and Torres Strait Islander Health Worker Association,
  • Speech Pathology Australia,

 

 

PAST UPDATES

To support health practitioners identify and assess people at risk of silicosis and improve patient health outcomes, the Federal Government has released the National Guidance for doctors assessing workers exposed to respirable crystalline silica dust.  

From the Department of Health's Webiste

The National Guidance for doctors assessing workers exposed to respirable crystalline silica dust (with specific reference to the occupational respiratory diseases associated with engineered stone) has been developed to help general practitioners identify and assess people at risk of silicosis caused by exposure to respirable crystalline silica dust. The recent re-emergence of silicosis is linked to the increasing popularity of engineered stone products, and the processes for cutting, grinding, and polishing this material.

Additional Infomrationis available from the Department of Health | National Guidance for doctors assessing workers exposed to respirable crystalline silica dust

Digital Mental Health Standards – Guide for service providers

The Commission is publishing the National Safety and Quality Digital Mental Health Standards – Guide for service providers.

The Guide provides practical advice on how to implement the Digital Mental Health Standards to improve safety and quality and ensure the best possible service is provided.

Working with the Standards

The Guide explains step-by-step each action of the Standards and their intention. It includes key tasks to help service providers meet the actions, together with examples of evidence a service can use to show how they are implementing the Standards. The Guide features reflective questions to help services evaluate how they are currently meeting the Standards and lists useful resources for further information and support.

Background

The Digital Mental Health Standards, launched in 2020 in response to increased use of mental health services over digital channels, aim to improve the quality of digital mental health service provision, and to protect service users and their support people from harm.

The Guide was developed by the Commission’s former Senior Clinical Advisor, Dr Peggy Brown AO, in consultation with clinicians, consumers and carers, digital mental health service providers and accrediting agencies. It has been reviewed by a wide range of stakeholders including experts in privacy and cyber security, digital technology, public health ethics and clinical safety.

More information

The Guide will be supported by fact sheets, webinars and resources to be released throughout 2022.

You can download the NSQDMH Standards – Guide for service providers from www.safetyandquality.gov.au/dmhs.

Contact the Commission at:

The ACNP has received correspondence from the Chief Medical Officer outlining the following key points for 2022

  • 2022 influenza vaccines for the National Immunisation Program will be available from April, subject to local supply arrangements
  • Influenza vaccines can be co-administered (on the same day) with COVID-19 vaccines.
  • It is even more important that people, especially those most vulnerable to complications from influenza, receive an influenza vaccine in 2022.

See the Acting CMO letter - early advice to stakeholders 2022 influenza season correspondence and a statement of ATAGI advice on seasonal influenza vaccines in 2022

 

We have a grant opportunity at Rural Workforce Agency Victoria available for health professionals who are looking to upskill in chronic pain management and would like support for costs of attending the upskilling events.

The grant will be open until 20 June 2022, with a cap of $5,000 per applicant.

Bursary payments can include contributions towards:

  • Short courses and/or workshops
  • Training that meets the professional development requirements of this grant opportunity
  • Recognised industry skills training and upskilling for eligible health professionals
  • Accommodation
  • Mileage
  • Air fares
  • Meals

More infomration at RWAV-Pain-Management-Grant-2022

As Lagevrio is being delivered to RACFs across Australia for the treatment of COVID 19, we have an important update on this medicine from our Chief Nursing and Midwifery Officer Alison McMillan.

As this treatment is not yet PBS approved, Product Information is not available on prescribing software, or in other drug information sources, so guidance and information is provided here for prescribers (including NPs) https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/two-anti-viral-covid-19-treatments-approved and also more information in this fact sheet: coronavirus-covid-19-use-of-lagevrio-molnupiravir-in-residential-aged-care_updated090222

We are very pleased to announce that the new National Aboriginal and Torres Strait Islander Health Plan 2021-2031 (Health Plan) was released on 15 December 2021.

The Health Plan sets the new nationally agreed policy framework to improve Aboriginal and Torres Strait Islander health outcomes over the next ten years. It has been developed in full and genuine partnership to reflect the priorities and perspectives of Aboriginal and Torres Strait Islander people.

In alignment with the new National Agreement on Closing the Gap, the Health Plan recognises the devastating impact that racism and discrimination have on Aboriginal and Torres Strait Islander people. Moving forward, governments and the mainstream health sector will need to work in partnership with Aboriginal and Torres Strait Islander people to ensure the whole health system is accountable for providing accessible, person-centred, culturally safe, and responsive care.

We thank you sincerely for your ongoing support throughout the development process. Your strong engagement provides a strong pathway forward to realise the vision of the Health Plan and transform our mainstream services.

We look forward to continuing to work with you to carry this strong engagement approach through to implementation.

For more information or to download copies of the Health Plan and its materials, please visit: https://www.health.gov.au/health-topics/aboriginal-and-torres-strait-islander-health/how-we-support-health/health-plan.

If you would like to receive hard copies, please contact the Strategic Policy Team at: ipag.secretariat@health.gov.au.

Thank you again and kind regards,

Gavin Matthews & the Health Plan team

Gavin Matthews

First Assistant Secretary | Indigenous Health Division | T: +61 2 6289 5314

Email: Gavin.Matthews@health.gov.au

Executive Assistant

Chieu Le

Chieu.le@health.gov.au

Ph: 02 6289 8565

Australian Government Department of Health

The Commission has released new resources for consumers and health service organisations to provide quick-reference summaries of the seven healthcare rights.

The Australian Charter of Healthcare Rights (the Charter) provides consumers, their families, carers and health service organisations with a shared understanding of healthcare rights.

For consumers, the new easy-to-read flyer might be included in welcome packs when they are admitted into hospital or for a day procedure. It describes what to expect when receiving healthcare, and is useful to help patients have conversations with their clinicians about healthcare rights.

For health service organisations, the flyer shares clear information summarising the key responsibilities of health services in upholding consumer rights.

The Commission has previously released a suite of supportive resources on the Charter including a comprehensive guide for consumers, an animation, audio resources, translations into 19 community languages, and Braille, Auslan and Easy English versions.

The Charter applies to care provided in all health settings, including public and private hospitals, general practice, dental services and other community settings. Please share these resources with anyone you know who may find them helpful.

For more information, email partneringwithconsumers@safetyandquality.gov.au or visit our Charter web page.

Australian Commission on Safety and Quality in Health Care
255 Elizabeth Street, Sydney, Australia 2000

 

DANA-logo-purple b

Connecting, Coaching and Changing Lives Program

Clinical support and mentoring workshops - Mentee Expression of Interest

Purpose of  the DANA  Mentorship Experience

EOI CLOSING 15 FEB 2022

Full details: DANA_Mentee_Expression_of_Interest February 2022 V3

"To provide guidance and support  to recently endorsed Nurse Practitioners  and aspiring Nurse Practitioners through a learning and development partnership allowing them to develop and advance their career."

The Connecting, Coaching and Changing Lives Program is a series of Clinical Support and  Mentoring Workshops that have been designed specifically for:

  • recently endorsed Drug and Alcohol (D&A)  Nurse Practitioners (NPs)
  • D&A NPs seeking increased support
  • NP Candidates and / or Transitional NPs who already work within the Alcohol and Other Drug  Sector
  • D&A nurses  enrolled in a Master of Nursing (Nurse Practitioner) program
  • NPs who work in other clinical settings with people who  have a drug / alcohol substance  use disorder.

  The program  offers clinical education as well as a group mentoring experience.

The program will be officially launched  online on Thursday February 24th, 2022, at 6:00pm (AEDT) or 5:00pm (AEST). Workshops will begin in March 2022.

Mentee Commitment

Mentees are required  to:

  • accept responsibility for their own growth and development
  • be willing to participate, be challenged,  ask questions, and seek clarification about any points not understood
  • explore opportunities for professional growth
  •  bring issues and challenges for discussion
  • approach the relationship with respect and openness
  • be available and committed to attending the pilot program of Clinical Support and Mentoring Workshops in its entirety (successful completion requires an 80% completion of all program activities) .

We ask prospective mentees to complete an Expression of Interest (EOI) which will be reviewed  by the DANA Committee.

Program length, inclusions, and activities

  • A pilot program to be run in 2022

Full details: DANA_Mentee_Expression_of_Interest February 2022 V3 EOI CLOSING 15 FEB 2022

Services Australia is upgrading its digital health and aged care channels

Services Australia is pleased to be working with Australian College of Nurse Practitioners to prepare you for the upgrades the agency is making to its digital health and aged care channels.
It is important that you understand these changes, as they may affect your business if you use software to submit claims and data to Services Australia.

To continue accessing Services Australia’s digital health and aged care channels, you’ll need to be using web service-compatible software by 13 March 2022.

If you use an alternative channel or don’t use software to transmit claims and data to the agency, you will not be affected by these upgrades. We want to make sure you know how these upgrades will impact you, and that you are ready before the March 2022 deadline.

What claiming channels are being upgraded?

Services Australia is upgrading the following online channels to web services:

  • Medicare Online
  • Department of Veterans’ Affairs (DVA) - via Medicare Online
  • Australian Immunisation Register (AIR) - via Medicare Online
  • ECLIPSE (Electronic Claim Lodgement and Information Processing Service Environment)
  • PBS Online
  • Aged Care Online

Services Australia is also strengthening its authentication process by replacing Public Key Infrastructure (PKI) site certificates with Provider Digital Access (PRODA) for organisations. PRODA is an online authentication system that verifies an organisation or individuals’ identity online. It enables secure access to multiple government online services, including Services Australia’s digital health and aged care channels.

More information about PRODA: servicesaustralia.gov.au/PRODA

What this means for you

If you still use a Medicare PKI site certificate to authenticate to any of these channels, you’ll need to upgrade your software and may need to register for PRODA before 13 March 2022. If your software isn’t upgraded by this date, your business may need to revert to manual processes or switch to other digital channels where available, for example, HPOS or the Aged Care Provider Portal. This may create disruption, additional administrative pressure and unnecessary costs.

What you need to do

Your software developer will have information on their transition and upgrade plans for your practice site. If you haven’t heard from them, contact them now and ask:

when will your web services compatible software be available

if you will need to register your organisation in Provider Digital Access (PRODA).

Important note: Medicare PKI certificates are used for purposes other than digital claiming or transmitting data to us. You may still need your PKI certificate to authenticate for other programmes.

For more information:

To access the web services eKit and factsheets to help you prepare for the change to web services and PRODA:  servicesaustralia.gov.au/hpwebservices

PRODA:

How to set up an individual PRODA account - http://medicareaust.com/MODULES/PRODA/PRODAM01_1/index.html

Registering your organisation in PRODA - http://medicareaust.com/MODULES/PRODA/PRODAM04_1/index.html

More information/guides - http://medicareaust.com/MISC/MISCP02/index.html

If you have any questions about the upgrade to web services, please contact servicesaustralia.A2WS@servicesaustralia.gov.au.

 

 

 

 

 

The TGA has approved the following COVID-19 self-tests (home use tests) for supply in Australia from 1 November 2021.

Please refer to the instructions on how to use each test for further information on what sample types the test can be used with.

The TGA's performance requirements for COVID rapid antigen self-tests are internationally aligned with technical specifications published by the World Health Organisation (WHO) and the European Commission. This includes a minimum clinical sensitivity of at least 80% (for specimens collected within 7 days of symptom onset) and a minimum clinical specificity of at least 98%.

Read more at https://www.tga.gov.au/covid-19-rapid-antigen-self-tests-are-approved-australia
 

Following on from the launch of the National Diabetes Nursing Education Framework and the accompanying 15 learning modules that support the framework, ADEA would like to take this opportunity to let you know about the launch of the National Diabetes Nursing Education Framework: learning workbook. This workbook forms part of the learning package developed to support the National Diabetes Nursing Education Framework. It is designed for those who are unable to access the associated online learning modules or who prefer workbook-style learning.

The aim of the National Diabetes Nursing Education Framework is to guide the development of a skilled nursing workforce that is capable of providing a high standard of diabetes care.

  • Part One describes four nursing practice levels in diabetes care: foundation, proficient, specialist and expert. There is also a pathway for nurses who want to build their competence and specialisation in diabetes.
  • Part Two outlines diabetes care and management competencies at each nursing practice level.
  • Part Three contains knowledge and skill statements listed under different aspects of diabetes care. Developing your knowledge and skills will help you to achieve the competencies listed in Part Two.

The framework is:

  • for all nurses, and it covers all types of diabetes across different ages and stages of life
  • a flexible and adaptable tool that promotes lifelong learning and can support the nursing profession to advance in the field of diabetes care and education with a long-term goal of improved community health outcomes.

All of the National Diabetes Nursing Education Framework resources are available at ndss.com.au

 

ADEA invites you to share these resources with your colleagues and relevant networks. If you have any questions or feedback please do not hesitate to get in touch.

13 December

ACNP Endorse the Delirium Clinical Care StandardClinical Care_Standards 

Thank you for your endorsement of the updated Delirium Clinical Care Standard, which was launched at the Australasian Delirium Association Conference, ‘DECLARED 2021’, by Associate Professor Gideon Caplan, President of the Australasian Delirium Association.

Supporting resources

22 December

Thank you for participating in the consultation workshops on aligning regulation across the care and support sector.  A new survey has been released for all stakeholders, including the broader community, to have their say on the alignment of regulation across the care and support sectors.  The online survey is open until Monday 10 January 2022 and takes about 10-12 minutes to complete. To take part in the survey, visit the following link. Please take the time to complete the survey today.  
To find out more about regulatory alignment, please refer to the background paper and consultation paper on the Department of Health website here or via https://www.health.gov.au/initiatives-and-programs/aligning-regulation-across-the-care-and-support-sectors.
Regards, The Cross Agency Taskforce on Regulatory Alignment
The Australian Government RegulatoryAlignmentTaskforce@Health.gov.au


21 December

Ahpra - Facilitating access to care in a COVID-19 environment - Guidance for health practitioners

A joint statement from the 15 National Boards and Ahpra is being published today to provide guidance to Australian registered health practitioners in relation to the facilitation of access to care in the current COVID-19 environment.  The guidance reinforces existing codes and guidelines and makes clear that National Boards expect practitioners to facilitate access to care regardless of someone’s vaccination status. People cannot be denied care if steps can be taken to keep the person, health practitioners and their staff safe.  

More information - please visit the Ahpra website or contact Helen Townley, National Director, Policy and Accreditation.


13 December

ACNP Endorse the Delirium Clinical Care StandardClinical Care_Standards 

Thank you for your endorsement of the updated Delirium Clinical Care Standard, which was launched at the Australasian Delirium Association Conference, ‘DECLARED 2021’, by Associate Professor Gideon Caplan, President of the Australasian Delirium Association.

Supporting resources


8 December

Updated ATAGI advice on the administration of seasonal influenza vaccines in 2021

The Australian Technical Advisory Group (ATAGI) has issued updated advice on the administration of seasonal influenza vaccine in 2021.  The Statement notes that with international borders gradually reopening from November 2021 and greater population movement, a resurgence of influenza activity is expected (potentially outside of the usual influenza season).  Influenza vaccination with the 2021 vaccine is recommended for anyone aged 6 months and over who has not had an influenza vaccine this year, particularly those in higher risk groups.  news item for health professionals linking to the updated  ATAGI advice on seasonal influenza vaccines in 2021 – December 2021 update has been published on the Department’s website.


6 December 

Nominations are open for the 2022 HESTA Australian Nursing and Midwifery Awards!  your stories are our inspiration…

Do you know a nurse or midwife with a story worth celebrating in the categories of:

• Midwife of the Year
• Nurse of the Year
• Outstanding Organisation

Winners will share in a $30,000 prize pool, courtesy of proud supporter ME - the bank for you.

Hurry, nominations close 06 February 2022.

NOMINATE NOW


3 December

Here is the Implanon NXT® (etonogestrel) Subdermal Implant Training Recommendations for Healthcare Professionals (HCPs) in Australia, with endorsements from key organisations including ACNP.  We hope these recommendations are a useful resource to HCPs to support training on insertion and removal of Implanon NXT.

Implanon NXT Training Recommendations for HCPs in Australia Final (002)


December 1

APNA’s annual Workforce Survey has provided a comprehensive picture of the working conditions and professional concerns of PHC nurses across Australia for more than 15 years:

  • It is the only national Survey focusing exclusively on nurses¿who work in primary health care. 
  • The findings from this year’s Survey will allow PHC nurses to highlight the professional issues in their day-to-day workplace with which they need more support and will also be used to advise the federal government on its 10-year reform agenda for primary health care. 
  • These survey findings would also be useful to your organisation, particularly for any workplace planning programs and objectives you may have.
  • APNA’s leadership team would be happy to provide briefings to your senior officers or executives when the survey results become available early in 2022.

The Survey was launched last week and has already been received well by the profession, however we are always looking for more responses. You will find the survey here: https://survey.alchemer.com/s3/6608519/366abba34877